Altered temporal response of malaria parasites determines differential sensitivity to artemisinin

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 13, 2013, Pages 5157-5162

  Klonis, Nectarios ^a   Xie, Stanley C ^a   McCaw, James M ^b   Crespo Ortiz, Maria P ^a   Zaloumis, Sophie G ^b   Simpson, Julie A ^b   Tilley, Leann ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Effective dose model; Endoperoxide; Plasmodium; Qinghaosu

Indexed keywords

ARTEMISININ; HEMOGLOBIN;

ANALYTIC METHOD; ARTICLE; DRUG EXPOSURE; DRUG RESPONSE; DRUG SENSITIVITY; IN VITRO STUDY; IN VIVO STUDY; PARASITE; PLASMODIUM; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TROPHOZOITE;

ARTEMISININS; DRUG RESISTANCE; LACTONES; MODELS, BIOLOGICAL; PLASMODIUM FALCIPARUM; SPECIES SPECIFICITY;

EID: 84875498942     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1217452110     Document Type: Article

References (34)

1. White NJ (2008) Qinghaosu (artemisinin): The price of success. Science 320(5874): 330-334.
2. Enserink M (2010) Malaria's drug miracle in danger. Science 328(5980):844-846.
3. Dondorp AM, et al. (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361(5):455-467.
4. Phyo AP, et al. (2012) Emergence of artemisinin-resistant malaria on the western border of Thailand: A longitudinal study. Lancet 379(9830):1960-1966.
5. Klonis N, et al. (2011) Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. Proc Natl Acad Sci USA 108(28):11405-11410.
6. Abu Bakar NA, Klonis N, Hanssen E, Chan C, Tilley L (2010) Digestive-vacuole genesis and endocytic processes in the early intraerythrocytic stages of Plasmodium falciparum. J Cell Sci 123(Pt 3):441-450.
7. Saralamba S, et al. (2011) Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 108(1):397-402.
8. ter Kuile F, White NJ, Holloway P, Pasvol G, Krishna S (1993) Plasmodium falciparum: In vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp Parasitol 76(1):85-95.
9. Benoit-Vical F, et al. (2007) Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob Agents Chemother 51(4): 1463-1472.
10. Skinner TS, Manning LS, Johnston WA, Davis TM (1996) In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Int J Parasitol 26(5):519-525.
11. German PI, Aweeka FT (2008) Clinical pharmacology of artemisinin-based combination therapies. Clin Pharmacokinet 47(2):91-102.
12. Eastman RT, Fidock DA (2009) Artemisinin-based combination therapies: A vital tool in efforts to eliminate malaria. Nat Rev Microbiol 7(12):864-874.
13. Duraisingh MT, Cowman AF (2005) Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop 94(3):181-190.
14. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF (2000) Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403(6772): 906-909.
15. Cui L, et al. (2012) Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum. Mol Microbiol 86(1):111-128.
16. Duraisingh MT, Roper C, Walliker D, Warhurst DC (2000) Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol Microbiol 36(4):955-961.
17. Charman SA, et al. (2011) Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc Natl Acad Sci USA 108(11):4400-4405.
18. Paguio MF, Bogle KL, Roepe PD (2011) Plasmodium falciparum resistance to cytocidal versus cytostatic effects of chloroquine. Mol Biochem Parasitol 178(1-2):1-6.
19. Krishna S, White NJ (1996) Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharmacokinet 30(4):263-299.
20. Geary TG, Divo AA, Jensen JB (1989) Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture. Am J Trop Med Hyg 40(3):240-244.
21. Meshnick SR, Taylor TE, Kamchonwongpaisan S (1996) Artemisinin and the antimalarial endoperoxides: From herbal remedy to targeted chemotherapy. Microbiol Rev 60(2):301-315.
22. Patel K, et al. (2013) Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria. Antimicrob Agents Chemother 57(1):508-516.
23. Tucker MS, Mutka T, Sparks K, Patel J, Kyle DE (2012) Phenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparum. Antimicrob Agents Chemother 56(1):302-314.
24. Teuscher F, et al. (2010) Artemisinin-induced dormancy in plasmodium falciparum: Duration, recovery rates, and implications in treatment failure. J Infect Dis 202(9): 1362-1368.
25. Witkowski B, et al. (2010) Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob Agents Chemother 54(5):1872-1877.
26. Bustamante C, et al. (2012) In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes. J Infect Dis 206(3):324-332.
27. O'Brien C, Henrich PP, Passi N, Fidock DA (2011) Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr Opin Infect Dis 24(6):570-577.
28. Mok S, et al. (2011) Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics 12:391.
29. Cheeseman IH, et al. (2012) A major genome region underlying artemisinin resistance in malaria. Science 336(6077):79-82.
30. Chavchich M, et al. (2010) Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum. Antimicrob Agents Chemother 54(6):2455-2464.
31. Fu Y, Tilley L, Kenny S, Klonis N (2010) Dual labeling with a far red probe permits analysis of growth and oxidative stress in P. falciparum-infected erythrocytes. Cytometry A 77(3):253-263.
32. Ranford-Cartwright LC, Sinha A, Humphreys GS, Mwangi JM (2010) New synchronization method for Plasmodium falciparum. Malar J 9:170.
33. R Development-Core-Team (2011) R: A Language and Environment for Statistical Computing (R Foundation, Vienna).
34. Witkowski B, et al. (2013) Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother 57(2):914-923.